title: Re: Chromogranin A concentration as a serum marker to predict prognosis after endocrine therapy for prostate cancer.
authors.forename: Masahiro
authors.initials: M
authors.lastname: Yashi
authors.forename: Akihiko
authors.initials: A
authors.lastname: Tokue
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood*; D053379:Chromogranin A; D002864:Chromogranins / Q000097:blood*; D006801:Humans; D008297:Male; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000628:therapy*; D015996:Survival Rate
chemical_list: D014408:Biomarkers, Tumor; C506150:CHGA protein, human; D053379:Chromogranin A; D002864:Chromogranins; D017430:Prostate-Specific Antigen